The healthcare system is constantly battling fraud, waste, and abuse, costing billions annually. While prescription drug schemes often dominate headlines, a more subtle but equally damaging form of healthcare fraud is gaining traction: dropshipping schemes involving durable medical equipment (DME). These schemes exploit vulnerabilities in the DME supply chain, inflating costs and diverting funds from legitimate patient care. Recent investigations by authorities and healthcare fraud detection teams are shedding light on this growing problem, revealing increasingly sophisticated tactics employed by unscrupulous actors.
Durable medical equipment, encompassing items like wheelchairs, orthotics, blood glucose monitors, and hospital beds, is essential for millions of patients managing chronic conditions or recovering from injuries. The Centers for Medicare & Medicaid Services (CMS) estimates that DME accounted for over $31 billion in Medicare spending in 2022, making it a significant target for fraudulent activity. CMS data highlights the substantial financial implications of DME fraud, underscoring the demand for vigilant oversight and proactive detection measures.
The core of a DME dropshipping scheme lies in circumventing traditional DME supply chains. Instead of manufacturing or legitimately sourcing equipment, fraudulent providers act as intermediaries, forwarding orders directly to large online retailers. They then bill health plans – including Medicare, Medicaid, and private insurers – at significantly inflated prices, pocketing the difference. This practice not only drains financial resources but as well raises concerns about the quality and suitability of the equipment provided to patients. The Department of Justice (DOJ) has been actively pursuing cases related to DME fraud, signaling a heightened focus on combating these schemes.
Identifying the Red Flags: Problematic Billing Patterns
Detecting DME dropshipping schemes requires a keen eye for anomalies in billing patterns. Investigators, like those at Cotiviti, a healthcare analytics company, are increasingly utilizing data analysis and peer comparisons to identify suspicious activity. Several key indicators can raise red flags, prompting further scrutiny. One common sign is a provider submitting claims for expensive orthotic devices at a disproportionately high frequency compared to other DME services. This could suggest an attempt to maximize profits through high-value items, regardless of actual patient need.
Another warning sign is billing for nebulizers and related supplies without a corresponding diagnosis in the patient’s medical record. Nebulizers are prescribed for respiratory conditions, and a lack of documented medical necessity raises concerns about inappropriate billing. Similarly, excessive billing for alginate dressings – used for wound care – on a large percentage of the patient population, coupled with high unit counts per patient, can indicate fraudulent practices. These patterns, when identified through data analysis, warrant a closer look at the provider’s billing practices.
Peer comparisons are crucial in identifying outlier providers. By comparing a provider’s billing data to that of their peers, investigators can pinpoint those who deviate significantly from the norm. For example, if a provider is billing for certain procedure codes at a much higher rate than other DME suppliers in the same region, it could be a sign of fraudulent activity. This comparative analysis helps to narrow down the scope of investigations and focus resources on the most suspicious cases.
The Investigation Process: Prepay Review and Documentation Requests
Once potential fraud is identified, health plans often implement a prepay review process. This involves requiring the provider to submit documentation supporting each claim *before* payment is issued. This allows investigators to verify the medical necessity of the equipment, the accuracy of the billing codes, and the legitimacy of the provider’s operations. In a recent case, Cotiviti placed a provider on prepay review for several procedure codes, including A4216 (sterile water, saline, or other drug diluent), A6196, A6197, A6198, and A6199 (alginate or other fiber gelling dressings), and L4361 (walking boot).
Over a nine-month period, Cotiviti reviewed approximately 130 claim lines submitted by the provider. A staggering 38% of these lines lacked sufficient documentation. Further investigation revealed that nearly 80% of the reviewed claims were ultimately denied due to documentation issues. Common reasons for denial included failure to meet surgical dressing benefit policy requirements, insufficient clinical documentation to support the patient’s condition, non-compliance with refill requirements, discrepancies between the prescription and the units billed, incorrect billing codes, and a lack of proof of delivery.
A particularly revealing discovery was the provider’s practice of submitting receipts from a major online retailer alongside their claims. Though, the provider was consistently billing the health plan approximately 70% more than the original purchase price from the retailer. This blatant markup demonstrated a clear intent to defraud the health plan and unjustly enrich themselves. In total, these findings prevented over $11,000 in inappropriate payments and prompted a referral for provider education.
Protecting Healthcare Funds: Key Takeaways for Health Plans
Combating DME dropshipping schemes requires a proactive and multi-faceted approach from health plans. Several key considerations can help protect both financial resources and patient well-being. Health plans must thoroughly review and adhere to specific guidelines established by CMS regarding the documentation required to support DME services. These guidelines outline the necessary medical records, prescriptions, and other supporting documentation needed to validate claims.
Regularly reviewing DME provider billing data is also crucial. Identifying outlier providers, supplies billed without appropriate diagnoses, and excessive units per patient can signal potential fraudulent activity. Health plans should carefully examine the differences between standard and custom DME equipment. Ensuring that appropriate protocols are followed when billing for custom items and preventing the substitution of standard, dropshipped items for custom-billed equipment is essential.
Finally, implementing robust medical record reviews and utilizing prepay review processes can effectively identify and stop future inappropriate billing behavior. By proactively scrutinizing claims and requiring supporting documentation, health plans can significantly reduce the risk of falling victim to DME dropshipping schemes. The DOJ’s ongoing efforts to prosecute these cases, such as the recent indictment of an Illinois man for a DME scheme in May 2024, as reported by the Department of Justice, demonstrate the seriousness with which these offenses are being treated.
Looking Ahead: Enhanced Oversight and Technological Solutions
The fight against DME fraud is ongoing, and healthcare stakeholders are continually seeking innovative solutions to address this evolving threat. The increasing adoption of advanced analytics and machine learning technologies, like Cotiviti’s 360 Pattern Review™ solution, offers promising avenues for proactive fraud detection. These tools can automate the identification of suspect billing behaviors, enabling health plans to intervene earlier and prevent significant financial losses.
strengthening collaboration between health plans, law enforcement agencies, and regulatory bodies is vital. Sharing information and coordinating investigations can help to dismantle complex fraud networks and bring perpetrators to justice. As the healthcare landscape continues to evolve, a commitment to vigilance, innovation, and collaboration will be essential in safeguarding healthcare funds and ensuring that patients receive the quality care they deserve. The Centers for Medicare &. Medicaid Services (CMS) continues to update its guidance on DME billing and compliance, and staying informed about these changes is crucial for all stakeholders. The CMS DME Coverage Manual provides detailed information on coverage criteria and billing requirements.
The next step in combating DME fraud will likely involve increased scrutiny of online retailer sales data and the development of more sophisticated algorithms to detect dropshipping patterns. Continued investment in fraud prevention technologies and a commitment to data-driven investigations will be critical in protecting the integrity of the healthcare system.
What are your thoughts on the increasing prevalence of DME fraud? Share your comments below, and let’s continue the conversation about protecting our healthcare system.
Related reading